0001762303 2023-05-11 2023-05-11 true 0001762303 8-K/A 2023-05-11 AVITA Medical, Inc. DE 001-39059 85-1021707 28159 Avenue Stanford Suite 220 Valencia CA 91355 661 367.9170 false false false false Common Stock, par value $0.0001 per share RCEL NASDAQ true false On May 12, 2023, AVITA Medical, Inc. (the “Company”) furnished a Current Report on Form 8-K (the “Original Form 8-K”) with a transcript of the Company’s May 11, 2023 conference call discussing the Company’s financial results for its fiscal quarter ended March 31, 2023 as Exhibit 99.2. Exhibit 99.2 to the Original Form 8-K inadvertently included extraneous tabular information from S&P Global Market Intelligence, including financial results and consensus data for the quarter ended March 31, 2023 in Australian Dollars. The Company’s actual results are reported in U.S. Dollars and included $10.6 million in revenue and a net loss of $9.2 million, or $0.37 per share. For further details, please refer to the Company’s Form 10-Q filed with the SEC on May 11, 2023. The information in Item 2.02 of this Current Report on Form 8-K/A is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.